11 March 2021
If you are interested in sponsoring the 2020 BioCapital Europe Conference please contact firstname.lastname@example.org or call +44 0750 0797 372
Event Organised by
LSP (Life Sciences Partners)
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.
For more information, please visit lspvc.com.
Gold Sponsors 2020 – Preconference drinks & fireside chat
LifeSci Advisors (www.lifesciadvisors.com) is the largest investor relations firm in the healthcare sector and provides life science companies tailored solutions to global investor access and communication. Our experienced team is made up of former healthcare equity sales professionals, investment bankers, portfolio managers – all with 15+ years of Wall Street experience – plus scientists, equity analysts and journalists. We leverage our domain expertise to secure quality, one-on-one time with investors for our clients. We understand our clients’ financial, R&D, regulatory, and commercial goals and challenges, and help them not only to win valuable face time with leading investors but also to communicate in ways that resonate with specialist healthcare investors. LifeSci is active in and has offices in multiple cities in the U.S, Europe, Israel and China.
Russell Reynolds Associates
Lunch Sponsor 2020
Coulter Partners is a board and senior level global executive search specialist focused exclusively on Life Sciences. We work closely with those at the cutting edge of innovation in the industry in order to understand their challenges. With an extensive global network and expertise gained over 25 years in the sector, we have become trusted advisers on leadership in the pharmaceuticals, biotechnology, medical devices, diagnostics, CRO and services sectors. We also work with the global investor community, hiring for their own teams as well as building the boards and executive leadership teams of their portfolios companies. The largest dedicated Life Science search boutique in North America and Europe, we work in a unique way. We share knowledge and connections across the globe, as one team with one goal. To bring clients the world’s best talent.
Lanyard Sponsor 2020
Pedersen & Partners
Pedersen & Partners , founded in 2001 by Poul Pedersen, is an integrated international Executive Search firm with 54 wholly owned offices in 50 countries and over 400 consultants and support staff across Europe, the Middle East, Africa, Asia & the Americas. Our values Trust, Relationship and Professionalism apply to our interaction with clients as well as executives.
Pedersen & Partners combines strong on-the-ground presence, with strong international practice groups. Our international team of dedicated Executive Search consultants works across all industry Practice Groups as a single, integrated international team to ensure that each client receives individual and customised attention.
Our dedicated Practice Groups assemble teams of international industry experts who bring up-to-date market knowledge and a track record of successfully supporting senior appointments in Biotech, MedTech as well as HealthTech. At the BioCapital event 2020, Pedersen & Partners will be represented by Figaro den Hollander, Country Manager (member of the Private Equity Practice), Lydia van der Meulen, Head Life Sciences & Healthcare Practice and Jaap den Hartog, our Biotech expert.
In addition to our international search expertise for executive positions, Pedersen & Partners also has a dedicated Board Practice for Non-Executives. We understand the importance of complex board governance issues, and the key roles that Board composition and effectiveness play in the successful and sustainable development of companies. We are aware that the cornerstone of a sound decision-making process when selecting candidates is the alignment of the board members’ skill sets with the company’s strategy, ownership structure and culture, and with international best practices. We always take into consideration current global trends, such as digital transformation, cyber security and risk management, regulation and compliance, diversity and transparency, reputation and integrity, independence and dedication, and shareholder empowerment.
Pedersen & Partners is 100% owned by a diverse team of Partners, who all work full-time to serve our clients. Operating as an integrated firm with one single profit centre, provides us with the unique capability to work as one team across the global organisation; and put the best team forward with industry, functional and geograhpical expertise.
Tea & Coffee Sponsor 2020
As a global professional services leader, EY’s Global Life Sciences Community brings together a worldwide network — more than 22,000 sector-focused advisory, assurance, tax, legal, and transaction professionals — to anticipate trends, identify their implications and develop points of view on responding to critical issues. EY works with market leading pharma, medtech, biotech and health industries, as well as life sciences scale-ups, startups, local life sciences clusters, care providers, insurers, and other key stakeholders in the health ecosystem. We help our clients in navigating their way forward and achieve sustainable successes in the new health-outcomes-driven ecosystem.
For our latest insights, please visit ey.com/lifesciences
- Leveraging in-depth life sciences market knowledge, an extensive external network of key life sciences & health stakeholders, and cultivating and demonstrating a deep understanding of the environments in which our clients operate, including the forces and challenges that shape their businesses.
- Leveraging local expertise by global connections: 260,000 people operating across four service lines, in 150+ countries and over 700 offices worldwide.
- Ability to assemble the right multidisciplinary teams, share leading practices, and address specific client needs, whatever worldwide location they are active in.
- Industry-recognized events, thought leadership, and insight documents in Life Sciences & Health including relocation and investment attractiveness barometers.
- Exceptional client service by proactively, visibly and timely sharing our knowledge, perspectives and experience – this is our mindset and culture
Drinks Reception Sponsor 2020
Loyens & Loeff
Loyens & Loeff offers top-level legal and tax advice for international businesses, financial institutions and government bodies.
Our Investment Management practice is the largest to offer a full range of investment management services in the Benelux. Our practice is multidisciplinary and closely integrated with other related practice areas, such as Private Equity (focusing specifically on private equity transactions such as leveraged buyouts and venture capital transactions), Tax, Real Estate and Banking & Finance. Our Investment Management practice also works closely with our firm’s Pharmaceuticals & Life Sciences Team and Healthcare Team, offering our clients in-depth sector knowledge, which enables us to offer truly integrated services.
Thanks to our closely collaborating legal and tax practices and our extensive sector knowledge, we have built up a unique and very solid position in the market, which enables us to effectively structuring and supervising both domestic and international matters.
Contributing Sponsors 2020
Allen & Overy
Allen & Overy Amsterdam is known for its individual experts and their ability to join forces, across practice areas and borders, to get deals done and to find solutions in highly complex cases. We are universally recognised market leaders in corporate transactions, banking & capital markets, governance & regulatory and disputes. Our global span of 44 offices with over 5,500 people and 550 partners covers established and emerging economies in the West and East and contains a network of over 90 highly experienced lawyers in life sciences.
We offer full-service and dedicated support for companies in the life sciences sector covering investments, start-ups and (venture) financing, mergers & acquisitions, IPO’s, capital market transactions, funds, intellectual property (contentious and non-contentious), regulatory and dispute resolution. Our experts have in-depth knowledge, presence and focus in the Dutch market and work together cross practice on a day-to-day basis. We cover all relevant areas, including pharma, biotech, medical devices, connected health, and consumer healthcare. Our unique experience of working with all relevant parties in the sector, from leading pharmaceutical, generics, biotech and medtech companies, as well as investors, universities and financial institutions has enhanced our ability to identify and anticipate the latest trends in the life sciences sector. Legal and regulatory developments in the Life Sciences sector are the topic of our dedicated blog, the Life Sciences Hub, and our CRISPR microsite, focusing on CRISPR related topics.
As a global top 40 law practice, Eversheds Sutherland provides legal services to a global client base ranging from small and mid-sized businesses to the largest multinationals, acting for 72 of the Fortune 100, 61 of the FTSE 100 and 120 of the Fortune 200.
With more than 2,800 lawyers, Eversheds Sutherland operates in 67 offices in 34 jurisdictions across Africa, Asia, Europe, the Middle East and the United States. In addition, a network of more than 200 related law firms, including formalized alliances in Latin America, Asia Pacific and Africa, provide support around the globe.
Our (international) Life Sciences Group is a highly recommended, multi-disciplinary legal team with extensive experience of the issues faced by the different sectors of the pharmaceutical, biosciences and medical devices industries. Specialists across the Group have extensive experience of the issues faced by the international biomedical industry with patent specialists across the world providing cutting-edge advice to the life sciences sector. Our Life Sciences Group is highly integrated and are able to advise you in multiple jurisdictions.
At Goodwin, we use law to achieve unprecedented results for our clients. Our 1,000 plus lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigations and world-class advisory services in the financial, life sciences, private equity, real estate, and technology industries. We partner with our clients to practice law with integrity, ingenuity, agility and ambition. Our integrated, full-service team with focused industry expertise helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle, and serve all legal needs of life sciences clients — corporate, partnering, regulatory, intellectual property and litigation. To learn more, visit us at www.goodwinlaw.com and follow us on Twitter at @goodwinlaw and on LinkedIn.
Kempen Corporate Finance
Kempen Corporate Finance is uniquely positioned as a dedicated specialist adviser in the life sciences & healthcare sector. Over the past years, we have built a strong position and extensive track-record in European IPOs and other capital market transactions and have emerged as a trusted adviser in various cross-border mergers & acquisitions and other advisory services. We combine our in depth knowledge of the financial sector with a scientific background and extensive business experience.